Early brain scan study after glioblastoma surgery
Part of Brain & nervous system, Cancer clinical trials.
This study tests whether it is safe and possible to do a special brain scan (nuclear imaging) within the first 3 days after surgery for glioblastoma. It may help doctors understand how well the tumor was removed and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery to remove a suspected glioblastoma within the past 72 hours.
- You are 18 years or older.
- You are not pregnant.
- You do not have any medical device or condition that prevents you from having an MRI scan (like severe claustrophobia).
- You are not allergic to the dyes used in the scans.
- You are able to give informed consent yourself.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced brain scans (PET and MRI) before surgery to understand how glioblastoma (an aggressive brain tumor) affects your brain's connections and thinking abilities. The goal is to help doctors better predict treatment outcomes and plan surgery more precisely.
This study uses special PET scans (fluciclovine and FDG) and advanced MRI to create a detailed metabolic profile of glioblastoma. It may help doctors better understand your tumor before surgery.
This study looks for connections between detailed brain scans and tumor genetic features in people with glioblastoma. It may help researchers find better ways to understand your tumor and tailor future care.
This trial tests whether using a special PET scan (a type of imaging that shows tumor activity) during brain tumor surgery helps doctors remove more of the tumor safely. You would have a high-grade glioma (an aggressive brain cancer) and be scheduled for surgery.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
This study tests whether a special radioactive scan that targets PSMA can help identify a high-grade brain tumor in people who are about to have surgery. It may help doctors better target treatment by confirming the tumor’s PSMA features using a radiolabeled imaging approach.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.